VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CROX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CROXCrocs, Inc.
$118.09$5.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCROXBalance Sheet

Crocs, Inc. (CROX) Balance Sheet

23Y historyFree accessUpdated daily

Leverage remains elevated with a D/E ratio of 1.22 and total debt of $1.7B, while cash of $170.3M is thin relative to debt, and goodwill has been halved to $404.6M, suggesting prior impairment.

Income StatementBalance SheetCash FlowRatios

CROX Balance Sheet

Annual statement

CROX Balance Sheet

Crocs, Inc. (CROX) balance sheet — 23-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03
Total Current Assets1.08B885.88M872.27M910.7M1.03B666.57M492.84M425.38M380.3M425.05M425.48M445.95M595.41M640.08M613.12M525.34M381.01M267.25M279.37M467.95M237.69M56.35M7.07M961K
Cash & Short-Term Investments170.28M130.35M180.49M149.29M191.63M213.26M137.34M109.75M125.31M174.27M150.1M143.34M267.51M317.14M294.35M257.59M145.58M78.49M51.66M36.63M67.87M4.79M1.05M326K
Cash Only170.28M130.35M180.49M149.29M191.63M213.26M137.34M109.75M125.31M174.27M150.1M143.34M267.51M317.14M294.35M257.59M145.58M1.14M51.66M300K45.55M4.79M1.05M326K
Short-Term Investments0000000000000000000022.32M000
Accounts Receivable453.19M333.06M283.91M331.23M329.19M217.18M162.52M118.25M108.37M97.83M95.93M108.08M122.54M126.98M122.71M110.88M84.96M75.21M59.72M152.92M65.59M18.03M3.25M178K
Days Sales Outstanding36.3530.0925.2630.5133.834.2742.835.0736.3534.8933.7936.1737.3338.8639.8740.4439.2742.5130.2165.8767.4960.6187.7955.77
Inventory389.21M368.69M356.25M385.05M471.55M213.52M175.12M172.03M124.49M130.35M147.03M168.19M171.01M162.34M164.8M129.63M121.16M93.33M143.21M248.39M86.21M28.49M2.41M448K
Days Inventory Outstanding82.1577.3976.8678.75101.5687.25100.5102.3486.0593.97100.1105.88102.68104.05116.73101.86120.85100.87107.39259.26204.12217.7123.03183.52
Other Current Assets4.92M53.79M51.62M45.13M33.61M65K1.54M1.5M1.95M2.14M2.53M2.55M4.19M4.44M6.28M7.05M15.89M7.36M24.78M12.44M6.58M000
Total Non-Current Assets3.27B3.29B3.94B3.73B3.48B878.5M625.88M313.42M88.6M118.65M140.91M162.07M211.52M235.08M216.52M170.11M168.47M142.48M176.63M159.47M61.77M21.68M9.15M343K
Property, Plant & Equipment583.63M576.86M551.56M525.75M421.43M269.17M224.89M229.63M22.21M35.03M44.09M49.49M68.29M86.97M82.24M67.68M70.01M71.08M95.89M88.18M34.85M14.77M3.73M318K
Fixed Asset Turnover6.97x7.00x7.44x7.54x8.44x8.59x6.16x5.36x48.99x29.22x23.50x22.04x17.55x13.71x13.66x14.79x11.28x9.08x7.53x9.61x10.18x7.35x3.63x3.66x
Goodwill404.64M404.69M711.49M711.59M714.81M1.6M1.72M1.58M1.61M1.69M1.48M1.97M2.04M2.51M2.73M000023.76M11.55M336K00
Intangible Assets1.32B1.32B1.78B1.79B1.8B28.8M37.64M47.09M45.69M56.43M72.7M82.3M97.34M72.31M57.2M48.64M45.46M35.98M40.89M31.63M12.21M5.31M5.43M10K
Long-Term Investments14.13M3.56M3.19M3.81M3.25M3.66M1.93M2.29M2.22M2.78M2.55M0000001.51M2.92M1.01M0000
Other Non-Current Assets50.8M44.03M24.21M31.45M7.87M8.07M8.93M8.07M8.21M12.54M13.27M23.3M25.97M53.66M40.24M23.41M18.28M15.43M15.69M7.13M2.3M733K015K
Total Assets4.36B4.17B4.81B4.64B4.5B1.55B1.12B738.8M468.9M543.7M566.39M608.02M806.93M875.16M829.64M695.45M549.48M409.74M456M627.42M299.46M78.03M16.22M1.3M
Asset Turnover0.94x0.97x0.85x0.85x0.79x1.50x1.24x1.67x2.32x1.88x1.83x1.79x1.48x1.36x1.35x1.44x1.44x1.58x1.58x1.35x1.18x1.39x0.83x0.89x
Asset Growth %-38.4%-13.25%3.62%3.16%191.37%38.11%51.42%57.56%-13.76%-4.01%-6.85%-24.65%-7.8%5.49%19.29%26.57%34.11%-10.14%-27.32%109.52%283.76%380.97%1144.17%-
Total Current Liabilities728.03M700.13M740.21M698.3M641.27M388.24M291.58M257.22M184.49M157.02M149.14M167.1M153.88M186.93M157.94M155.3M137.76M86.66M133.53M167.45M87.91M46.3M8.86M746K
Accounts Payable262.51M266.09M264.9M260.98M230.82M162.15M112.78M95.75M77.23M66.38M61.93M63.34M42.92M57.45M63.98M66.52M35.67M23.43M35.14M82.98M43.79M20.83M3.05M431K
Days Payables Outstanding52.355.8657.1553.3749.7166.2664.7256.9753.3847.8642.1639.8725.7736.8245.3152.2735.5825.3326.3586.61103.69159.14155.34176.56
Short-Term Debt0068.55M85.59M81.82M42.93M47.06M48.59M0676K2.34M4.77M5.29M5.18M9.98M1.12M1.9M640K22.43M7.11M541K8.5M978K0
Deferred Revenue (Current)00006.8M100K000000000000000000
Other Current Liabilities174.93M184.84M216.8M215.53M177.15M103.84M77.83M66.22M58.2M49.49M57.38M71.6M60.9M70.21M53.71M47.83M33.82M35.19M41.34M34.83M21.39M6.34M3.96M0
Current Ratio1.49x1.27x1.18x1.30x1.60x1.72x1.69x1.65x2.06x2.71x2.85x2.67x3.87x3.42x3.88x3.38x2.77x3.08x2.09x2.79x2.70x1.22x0.80x1.29x
Quick Ratio0.96x0.74x0.70x0.75x0.86x1.17x1.09x0.98x1.39x1.88x1.87x1.66x2.76x2.56x2.84x2.55x1.89x2.01x1.02x1.31x1.72x0.60x0.53x0.69x
Cash Conversion Cycle66.251.6244.9755.8985.6555.2678.5880.4569.028191.73102.18114.24106.09111.2990.03124.54118.05111.25238.52167.92119.1755.4862.73
Total Non-Current Liabilities2.24B2.18B2.24B2.49B3.04B1.14B536.51M349.67M134.1M18.38M17.97M19.29M27.85M63.49M54.3M48.37M35.61M35.46M35.3M15.86M3.29M12.81M10.96M2.2M
Long-Term Debt1.31B1.23B1.35B1.64B2.3B771.39M180M205M120M040K1.63M6.38M11.67M4.6M00912K09K03.21M1.41M0
Capital Lease Obligations1.19B297.19M283.41M269.77M215.12M149.24M146.4M140.15M000000000000116K000
Deferred Tax Liabilities3.68M882K4.09M12.91M302.03M176K00000011.87M11.2M2.4M2.89M847K2.19M2.92M1.86M1.69M1.77M1.78M0
Other Non-Current Liabilities643.66M653.26M599.38M567.94M227.42M222.12M210.1M4.53M14.1M18.35M17.93M17.67M21.47M51.82M49.7M48.34M34.77M32.36M32.39M14M1.49M528K2.25M2.2M
Total Liabilities2.97B2.88B2.98B3.19B3.68B1.53B828.09M606.9M318.59M175.4M167.11M186.39M181.73M250.41M212.24M203.67M173.38M122.12M168.84M183.31M91.2M59.12M19.82M2.95M
Total Debt1.69B1.61B1.7B2B2.59B963.56M373.46M393.73M120M676K2.38M6.4M11.67M16.85M14.58M1.12M1.9M1.55M22.43M7.12M657K11.72M2.39M0
Net Debt1.52B1.48B1.52B1.85B2.4B750.3M236.12M283.98M-5.31M-173.57M-147.72M-136.94M-255.84M-300.3M-279.77M-256.44M-143.68M408K-29.23M6.82M-44.89M6.93M-76K-326K
Debt / Equity1.22x1.25x0.93x1.37x3.17x68.42x1.29x2.98x0.80x0.00x0.01x0.02x0.02x0.03x0.02x0.00x0.01x0.01x0.08x0.02x0.00x0.62x--
Debt / EBITDA1.92x1.67x1.56x1.81x2.92x1.35x1.54x2.58x1.30x0.01x0.09x-0.36x0.16x0.08x0.01x0.02x--0.03x0.01x0.39x--
Net Debt / EBITDA1.72x1.53x1.39x1.68x2.70x1.05x0.98x1.86x-0.06x-3.44x-5.30x--7.83x-2.87x-1.53x-1.52x-1.22x--0.03x-0.43x0.23x--
Interest Coverage321.74x1.83x9.33x6.43x6.28x31.67x31.70x14.82x69.23x21.92x-7.63x-76.14x-9.61x60.01x174.89x161.25x123.97x-31.52x-104.69x542.85x168.16x572.17x--
Total Equity1.38B1.29B1.84B1.45B817.93M14.08M290.63M131.91M150.31M368.3M399.28M421.63M625.2M624.74M617.4M491.78M376.11M287.62M287.16M444.11M208.26M18.91M-3.59M-1.64M
Equity Growth %-80.63%-29.55%26.26%77.76%5708.34%-95.15%120.34%-12.24%-59.19%-7.76%-5.3%-32.56%0.07%1.19%25.54%30.76%30.76%0.16%-35.34%113.25%1001.08%626.71%-118.7%-
Book Value per Share27.6023.8630.6823.4713.190.224.241.842.205.105.415.597.347.196.775.414.293.383.475.271.300.28-0.07-0.02
Total Shareholders' Equity1.38B1.29B1.84B1.45B817.93M14.08M290.63M131.91M150.31M368.3M399.28M421.63M625.2M624.74M617.4M491.78M376.11M287.62M287.16M444.11M208.26M18.91M-3.59M-1.64M
Common Stock111K111K110K110K110K106K105K104K103K95K94K94K92K92K91K90K88K85K84K83K39K17K1.92M394K
Retained Earnings3.82B3.48B3.56B2.61B1.82B1.28B553.35M240.49M121.22M190.43M195.72M227.46M325.47M344.43M334.01M202.67M89.88M22.16M64.23M249.31M81.08M16.7M-3.67M-2.04M
Treasury Stock-3.3B-3.04B-2.45B-1.89B-1.7B-1.68B-688.85M-546.21M-397.49M-334.31M-284.24M-283.91M-200.42M-55.96M-44.21M-19.76M-22.01M-25.26M-25.02M-25.02M0000
Accumulated OCI-63.43M-43.66M-132.65M-95.77M-103.49M-76.84M-56.35M-58.38M-54.65M-43.39M-55.6M-50.91M-18.35M14.65M19.69M14.82M30.85M24.17M15.83M7.81M-4.7M-11.78M-12.88M-83K
Minority Interest000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetMixed
Cash FlowStable
Top Statement Risk

Unresolved net margin divergence

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Stabilizing After Deleveraging

Total assets have contracted from $4.8B in 2024Q1 to $4.4B in 2026Q2, while equity has declined from $1.6B to $1.4B, indicating a shrinking balance sheet. According to the latest quarterly data, the D/E ratio has improved from 1.29 to 1.22, suggesting gradual deleveraging.

The reduction in total assets is primarily driven by a $307M decrease in goodwill, which fell from $711.6M in 2024Q1 to $404.6M in 2026Q2, likely reflecting an impairment charge. This, combined with stable PPE and modest cash accumulation, suggests the balance sheet is consolidating after the HEYDUDE acquisition. The equity decline is partly due to share repurchases, which have totaled over $1.4B in the last ten quarters, offsetting retained earnings growth.

Leverage Remains Elevated Despite Modest Reduction

Total debt has decreased from $2.1B in 2024Q1 to $1.7B in 2026Q2, yet the D/E ratio of 1.22 remains high relative to peers like DECK at 0.15. As reported in the balance sheet data, debt levels are stable around $1.7B, indicating a slow deleveraging pace.

The debt-to-equity ratio has hovered between 0.93 and 1.29 over the past ten quarters, with the current 1.22 suggesting the company is still carrying significant leverage from the HEYDUDE acquisition. Interest expenses are likely a major contributor to the persistent gap between operating margin (22.0%) and net margin (-2.0%), as the income statement shows a net loss despite strong operating income. This leverage may be strategic to fund buybacks, but it also amplifies downside risk if consumer demand softens.

Asset Mix Reflects Shift to Asset-Light Model

Goodwill has been halved from $711.6M in 2024Q1 to $404.6M in 2026Q2, while PPE has grown modestly from $523.0M to $583.6M, indicating a reduced reliance on acquired intangibles. Based on the balance sheet data, the asset base is increasingly composed of tangible assets.

The significant reduction in goodwill suggests an impairment charge, likely related to the HEYDUDE brand, which may indicate that the acquisition has not performed as expected. PPE growth of 11.5% over the period is modest, consistent with the low capital intensity of the injection-molding model. The asset mix now leans more toward operational assets, which could improve asset quality but also signals that the company is investing in its own capacity rather than relying on acquisitions.

Equity Quality Weakened by Buybacks and Impairments

Retained earnings have grown from $2.8B in 2024Q1 to $3.8B in 2026Q2, but total equity has declined from $1.6B to $1.4B, reflecting aggressive share repurchases. According to the cash flow statement, buybacks totaled $256.9M in 2026Q2 alone, exceeding net income.

The company has been returning substantial capital to shareholders through buybacks, which have reduced the share count and boosted EPS, but this has also depleted equity. The retained earnings growth is positive, indicating cumulative profitability, but the equity base is shrinking due to buybacks and the goodwill impairment. This suggests that management is prioritizing shareholder returns over balance sheet strength, which could be a concern if leverage remains high.

Liquidity Adequate but Cash Buffer Thin

The current ratio improved to 1.49 in 2026Q2 from 1.27 in 2025Q4, but cash of $170.3M is modest relative to total debt of $1.7B. As reported in the balance sheet data, the quick ratio is likely below 1.0, indicating limited short-term liquidity.

While the current ratio is above 1.0, the cash position is only 10% of total debt, suggesting that the company relies on operating cash flow to service its obligations. The seasonal working capital swings, as noted in the cash flow analysis, can cause liquidity to tighten in certain quarters. However, the strong operating cash flow generation, with a trailing twelve-month FCF margin of 18%, provides a buffer against short-term shocks.

Goodwill Impairment Masks Underlying Asset Quality

The $307M reduction in goodwill from 2024Q1 to 2026Q2, combined with a persistent gap between operating and net margins, suggests that the HEYDUDE acquisition may have suffered an impairment. According to the balance sheet data, this non-cash charge has distorted equity and asset trends.

The impairment, likely recorded in 2025Q2 when net income was -$492.3M, has reduced the asset base and equity, but it also indicates that the acquisition has not generated the expected returns. This could signal that the HEYDUDE brand is underperforming, which may have implications for future revenue growth. Investors should monitor whether further impairments are likely, as they could continue to erode equity and mask the true profitability of the core Crocs brand.

CROX — Frequently Asked Questions

Quick answers to the most common questions about buying CROX stock.

What are the total assets of Crocs, Inc. (CROX)?

As of 2025, Crocs, Inc. (CROX) had total assets of $4.17B including $885.9M in current assets.

How much debt does Crocs, Inc. (CROX) have?

Crocs, Inc. (CROX) carries total debt of $1.61B, offset by $130.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Crocs, Inc.?

Crocs, Inc. (CROX) has total shareholders' equity (book value) of $1.29B ($23.86 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Crocs, Inc.'s current ratio and liquidity?

Crocs, Inc. (CROX) reported a current ratio of 1.27x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.